Clinical Outcomes and Safety of Intravenous Polymyxin B-based Treatment in Critically Ill Patients with Carbapenem-resistant Acinetobacter baumannii Nosocomial Pneumonia.

Luyao Qiao,Wei Zuo,Yang Yang,Xin Liu,Qianlin Wang,Jiaxin Yu,Jiayu Wu,Tingting Xu,Jiandong Jiang,Bo Zhang,Yun Long

International Journal of Antimicrobial Agents（2023）

引用 0|浏览16

暂无评分

摘要

PMB in combination with SB may be a promising treatment option for patients with CRAB-induced nosocomial pneumonia, as mortality was significantly reduced with low-dose PMB and no increased risk of nephrotoxicity was observed.

查看译文

关键词

Carbapenem-resistant Acinetobacter baumannii,Nosocomial pneumonia,Polymyxin B,Sulbactam,Tigecycline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要